轻度甲型血友病的诊断需要进行一期法和发色底物法凝血因子 VIII 测定。 - Suppr | 超能文献

Both one-stage and chromogenic factor VIII assays are required for the diagnosis of mild hemophilia A.

作者信息

Kitchen Steve, Bowyer Annette, Makris Mike

机构信息

Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, UK.

Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, UK.

出版信息

J Thromb Haemost. 2023 Apr;21(4):773-775. doi: 10.1016/j.jtha.2022.12.013.

DOI:10.1016/j.jtha.2022.12.013

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Both one-stage and chromogenic factor VIII assays are required for the diagnosis of mild hemophilia A.轻度甲型血友病的诊断需要进行一期法和发色底物法凝血因子 VIII 测定。

J Thromb Haemost. 2023 Apr;21(4):773-775. doi: 10.1016/j.jtha.2022.12.013.

2

Comparative analysis of chromogenic vs clot.based one stage APTT assay for determination of factor VIII level.发色底物法与凝固法一步法 APTT 检测凝血因子Ⅷ活性的比较分析。

Indian J Pathol Microbiol. 2021 Jan-Mar;64(1):123-127. doi: 10.4103/IJPM.IJPM_900_19.

3

Chromogenic Factor VIII Assays for Improved Diagnosis of Hemophilia A.用于改善甲型血友病诊断的显色性凝血因子 VIII 检测

Methods Mol Biol. 2017;1646:265-276. doi: 10.1007/978-1-4939-7196-1_21.

4

Little discrepancy between one-stage and chromogenic factor VIII (FVIII)/IX assays in a large international cohort of persons with nonsevere hemophilia A and B.在一个大型国际非重度血友病A和B患者队列中，一步法与发色底物法检测因子VIII（FVIII）/IX的结果差异不大。

J Thromb Haemost. 2023 Apr;21(4):850-861. doi: 10.1016/j.jtha.2022.11.040. Epub 2022 Dec 22.

5

Specific and global coagulation assays in the diagnosis of discrepant mild hemophilia A.特定和整体凝血检测在不一致性轻型血友病 A 诊断中的应用。

Haematologica. 2013 Dec;98(12):1980-7. doi: 10.3324/haematol.2013.088088. Epub 2013 Jun 28.

6

One-stage clotting versus chromogenic assays for assessing recombinant factor VIII: two faces of a haemostasis coin.用于评估重组凝血因子VIII的一步凝血法与发色底物法：止血之币的两面

Blood Coagul Fibrinolysis. 2009 Jan;20(1):1-3. doi: 10.1097/mbc.0b013e32831bc324.

7

Discrepancy between the results of one-stage and chromogenic factor VIII: C assays in patients with mild/moderate hemophilia A.一期法和显色因子 VIII:C 检测在轻/中度血友病 A 患者中的结果差异。

Blood Coagul Fibrinolysis. 2020 Dec;31(8):530-535. doi: 10.1097/MBC.0000000000000959.

8

Clinical application of a chromogenic substrate method for determination of factor VIII activity.一种用于测定因子VIII活性的显色底物法的临床应用。

Thromb Haemost. 1985 Dec 17;54(4):818-23.

9

One-stage vs. chromogenic assays in haemophilia A.血友病A的一步法检测与显色法检测对比

Eur J Haematol. 2015 Feb;94 Suppl 77:38-44. doi: 10.1111/ejh.12500.

10

Discrepancies between the one-stage clotting assay and chromogenic assay in patients with hemophilia A receiving standard or extended half-life factor VIII products in clinical settings.

Thromb Res. 2020 Jan;185:150-152. doi: 10.1016/j.thromres.2019.11.020. Epub 2019 Nov 20.

引用本文的文献

1

Nonsevere Hemophilia: The Need for a Renewed Focus and Improved Outcomes.非重度血友病：需要重新聚焦并改善治疗结果。

Semin Thromb Hemost. 2025 Feb;51(1):58-67. doi: 10.1055/s-0044-1786358. Epub 2024 May 11.